- Home
- LNTH vs HASI Comparison
LNTH vs HASI Comparison
Compare LNTH & HASI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LNTH
- HASI
- Stock Information
- Founded
- LNTH 1956
- HASI 1981
- Country
- LNTH United States
- HASI United States
- Employees
- LNTH N/A
- HASI N/A
- Industry
- LNTH Biotechnology: In Vitro & In Vivo Diagnostic Substances
- HASI Real Estate Investment Trusts
- Sector
- LNTH Health Care
- HASI Real Estate
- Exchange
- LNTH Nasdaq
- HASI Nasdaq
- Market Cap
- LNTH 3.6B
- HASI 3.4B
- IPO Year
- LNTH 2015
- HASI 2013
- Fundamental
- Price
- LNTH $52.99
- HASI $27.99
- Analyst Decision
- LNTH Strong Buy
- HASI Strong Buy
- Analyst Count
- LNTH 5
- HASI 6
- Target Price
- LNTH $91.60
- HASI $37.67
- AVG Volume (30 Days)
- LNTH 1.6M
- HASI 914.7K
- Earning Date
- LNTH 11-05-2025
- HASI 11-06-2025
- Dividend Yield
- LNTH N/A
- HASI 5.93%
- EPS Growth
- LNTH N/A
- HASI N/A
- EPS
- LNTH 3.77
- HASI 1.59
- Revenue
- LNTH $1,520,653,000.00
- HASI $92,418,000.00
- Revenue This Year
- LNTH N/A
- HASI $187.82
- Revenue Next Year
- LNTH $3.24
- HASI $14.06
- P/E Ratio
- LNTH $14.58
- HASI $17.84
- Revenue Growth
- LNTH 5.75
- HASI N/A
- 52 Week Low
- LNTH $47.25
- HASI $21.98
- 52 Week High
- LNTH $118.21
- HASI $36.56
- Technical
- Relative Strength Index (RSI)
- LNTH 38.84
- HASI 54.45
- Support Level
- LNTH $51.94
- HASI $27.48
- Resistance Level
- LNTH $55.24
- HASI $28.53
- Average True Range (ATR)
- LNTH 1.97
- HASI 0.50
- MACD
- LNTH 0.48
- HASI -0.03
- Stochastic Oscillator
- LNTH 15.34
- HASI 40.74
About LNTH Lantheus Holdings Inc.
Lantheus Holdings Inc caters to the United States healthcare sector with the development of diagnostic products. Its products are in three categories: Precision Diagnostics, Radiopharmaceutical Oncology, and Strategic Partnerships and Other Revenue. Precision Diagnostic products assist healthcare professionals Find and Follow diseases, with a focus in cardiology. Radiopharmaceutical Oncology diagnostics and therapeutics help HCPs Find, Fight and Follow cancer. Strategic Partnerships focus on enabling precision medicine through the use of biomarkers, digital solutions and pharma services platforms, and also includes license of RELISTOR to Bausch Health Companies, Inc.
About HASI Hannon Armstrong Sustainable Infrastructure Capital Inc.
HA Sustainable Infrastructure Capital Inc is an investor in sustainable infrastructure assets advancing the energy transition. Its investment is focused on actively partnering with clients to deploy capital in income-generating real assets that are supported by long-term recurring cash flows. This enabled to the generation of attractive risk-adjusted returns and provided stockholders with diversified exposure to the energy transition.